-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ERt4Cwai70IpHLYbkLXZZLyrWzkjS+HZZssU+ru15/IZWrpFm9MFwrpBpV5wBIBl 830jlYGy0gH3ncFQyJ/1cA== 0001454982-10-000022.txt : 20100204 0001454982-10-000022.hdr.sgml : 20100204 20100204191945 ACCESSION NUMBER: 0001454982-10-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100202 FILED AS OF DATE: 20100204 DATE AS OF CHANGE: 20100204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRADBURY DANIEL CENTRAL INDEX KEY: 0001236397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 10575334 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-02-02 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236397 BRADBURY DANIEL 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 1 1 0 0 President & Chief Executive Of Common Stock 2010-02-03 4 A 0 412 17.83 A 16524 D Common Stock 2010-02-03 4 A 0 1360 0 A 4815 I by ESOP Common Stock 42012 I by Trust Common Stock 6263 I by Trust-1 Incentive Stock Option (right to buy) 18.01 2010-02-02 4 A 0 5552 0 A 2017-02-02 Common Stock 5552 5552 D Non-Qualified Stock Option (right to buy) 18.01 2010-02-02 4 A 0 244448 0 A 2017-02-02 Common Stock 244448 244448 D Represents shares acquired pursuant to the Company's 401(k) plan. Includes 2,913 shares acquired on August 31, 2009 under the company's employee stock purchase plan and fractional share amounts deposited to participant's 401(k) account by trustee to cover interest accrued on cash balances in the plan's stock fund. These shares fully vest four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment. Shares held by the Bradbury Gift Trust, of which the reporting person's minor children are beneficiaries. 25% of shares vest one year from date of grant and the remainder vest monthly over the next three years becoming fully vested four years from date of grant. By: /s/James R. Oehler, Attorney-in-Fact For: Daniel M. Bradbury 2010-02-04 -----END PRIVACY-ENHANCED MESSAGE-----